1. Androgen-deprivation therapy in prostate cancer: a European expert panel review;Schulman;Eur Urol Suppl,2010
2. Parenteral oestrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer;Hedlund;Scand J Urol Nephrol,2008
3. Therapy insight: parenteral oestrogen treatment for prostate cancer—a new dawn for an old therapy;Ockrim;Nat Clin Prac Oncol,2006
4. PATCH (MRC PR09): A randomised controlled trial of transcutaneous oestrogen patches versus LHRH analogues in prostate cancer. Medical Research Council Clinical Trials Unit Web site. http://www.ctu.mrc.ac.uk/research_areas/study_details.aspx?s=23.
5. Langley RE, Kynaston H, Clarke N, et al. PATCH, a randomized phase II trial of oestrogen patches versus LHRH as first-line hormonal therapy for prostate cancer: planned interim analysis results [abstract 173]. Abstract presented at: 2009 Genitourinary Cancers Symposium; February 26–28, 2009; Orlando, FL, USA. http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst_detail_view&confID=64&abstractID=20418.